Comèl-Netherton syndrome defined as primary immunodeficiency. - Wikidata - awgldk - TriplyDB

Comèl-Netherton syndrome defined as primary immunodeficiency.

Comèl-Netherton syndrome defined as primary immunodeficiency.

http://www.wikidata.org/entity/Q34997608

about

Primary immunodeficiencies associated with eosinophilia Eosinophilia Associated with Disorders of Immune Deficiency or Immune Dysregulation Tissue Kallikrein Inhibitors Based on the Sunflower Trypsin Inhibitor Scaffold - A Potential Therapeutic Intervention for Skin Diseases Patterns of Allergic Sensitization in High IgE Syndromes.Advances in basic and clinical immunology in 2009 Care of the newborn with ichthyosis.The role of the skin microbiome in atopic dermatitis.Identifying Mutations of the Tetratricopeptide Repeat Domain 37 (TTC37) Gene in Infants With Intractable Diarrhea and a Comparison of Asian and Non-Asian Phenotype and Genotype: A Global Case-report Study of a Well-Defined Syndrome With Immunodefici Additional diverse findings expand the clinical presentation of DOCK8 deficiency.Natural killer cell deficiency.Transgenic kallikrein 5 mice reproduce major cutaneous and systemic hallmarks of Netherton syndrome.Malignant skin tumours in patients with inherited ichthyosis.Indications and safety of intravenous and subcutaneous immunoglobulin therapy.Skin manifestations of primary immune deficiency.Chemokines, their receptors and human disease: the good, the bad and the itchy.Betapapillomavirus in multiple non-melanoma skin cancers of Netherton syndrome: Case report and published work review.Different brands of intravenous immunoglobulin for primary immunodeficiencies: how to choose the best option for the patient?Atopic Dermatitis and Allergic Urticaria: Cutaneous Manifestations of Immunodeficiency.Netherton Syndrome: A Genotype-Phenotype Review.Netherton Syndrome Mimicking Pustular Psoriasis: Clinical Implications and Response to Intravenous Immunoglobulin.Updated strategies for the management, pathogenesis and molecular genetics of different forms of ichthyosis syndromes with prominent hair abnormalities.[Atopic eczema in childhood or primary immunodeficiency - what needs to be considered?]From clinical observations and molecular dissection to novel therapeutic strategies for primary immunodeficiency disorders.An 8-Year-Old Child with Delayed Diagnosis of Netherton Syndrome.

P2860

Q26746046-DD0D0900-5C83-4732-83AE-8CAC0523CC7A Q26799603-992EB568-1F4E-4201-8C32-8E6BCB61B3C9 Q28553241-E3B3A72C-3AED-4C8A-922B-65538B783D57 Q30278478-2A366BDA-F8F7-4C3F-83C0-AFEE68D4F806 Q33737600-DD995DB8-9B23-4ADC-8D0D-863EBF4CC954 Q34035416-377D94A0-68A6-4CB1-B0F6-4D3CDA3C3921 Q35787272-50DF161E-DC7A-47ED-B694-4730D0B0AB6A Q36663991-16AF3716-0BB1-4B96-B25E-1B2F6133DF50 Q37068033-6649E218-1D98-4300-8AFC-C7DC3BA551C4 Q37567421-A51E30E2-B7AE-4682-BED7-FA74838E66A6 Q37630234-6BB9B2B4-F730-4707-AC5D-B908C8454418 Q37868636-5EF6922D-2BAA-4B69-9522-7021DF2D45B0 Q37877259-8311D03E-2849-4631-A079-6EB5035FFAAB Q38113986-F19A1DCC-9AC7-4538-810F-696E969E7B91 Q38431506-DE891E6A-53D2-46BC-BB33-D09A8DE18600 Q38445240-AD0F8BF1-90E0-4C62-AD61-7CE7AF040144 Q38569717-266CA921-B449-49FB-81C1-2169CFFB830C Q39019860-71506B2D-3D50-480D-8D18-685F386954EA Q39025260-8A81CF4F-07EC-42DF-9774-3C7372C26F2C Q46755538-0258E655-F74E-48F7-87F9-E29F02E4C755 Q47693815-5256065C-3DE3-4676-8371-38F8DF1AF9CF Q49844868-EE5973E9-36C7-48D3-9CE2-83734DB1C95D Q53061634-4EBD65D9-12BE-4957-8914-1B7D30A1CDA1 Q55071346-DBF10018-CF4C-4CF5-8774-184FB688C7BB

P2860

Comèl-Netherton syndrome defined as primary immunodeficiency.

http://www.wikidata.org/entity/Q34997608

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Comèl-Netherton syndrome defined as primary immunodeficiency.

@ast

Comèl-Netherton syndrome defined as primary immunodeficiency.

@en

Comèl-Netherton syndrome defined as primary immunodeficiency.

@nl

type

label

Comèl-Netherton syndrome defined as primary immunodeficiency.

@ast

Comèl-Netherton syndrome defined as primary immunodeficiency.

@en

Comèl-Netherton syndrome defined as primary immunodeficiency.

@nl

prefLabel

Comèl-Netherton syndrome defined as primary immunodeficiency.

@ast

Comèl-Netherton syndrome defined as primary immunodeficiency.

@en

Comèl-Netherton syndrome defined as primary immunodeficiency.

@nl

P1433

Q34997608-2C1ED8DF-E2BC-4A11-9AE6-6179BED101CB

P1476

Q34997608-ED049306-A874-4EF2-8BAC-3D58422B1A57

P2093

Q34997608-049C4C75-7B92-4C36-89D0-67F40AA737D1

Q34997608-214D0A44-8296-4952-B1BB-4791F02B7027

Q34997608-228723DB-B0FF-4CB6-81E7-0DAF45FC83C7

Q34997608-5D6BD670-3E0A-4803-B507-BA74E85FBE26

Q34997608-BB435E50-F193-4C8D-AE05-E3BC18D504CC

Q34997608-C66A7AD8-CBB6-4A9A-A446-09AE741A2C1C

Q34997608-C7756999-70A2-41C5-A477-C212306D0EEC

Q34997608-D04282F0-066B-49C7-AB34-D8A7506451E1

Q34997608-D4DA17BE-7E37-4BCE-B300-03F2BAD9C526

Q34997608-DFD05D74-4164-4447-8AE8-D6737211C54D

P2860

Q34997608-0A3C06F8-3F0D-4D40-8E36-69C862F0CA03

Q34997608-0E1A4472-FCE3-43F4-B747-134BFB5DF53B

Q34997608-11FA9893-2F7E-4818-ADB0-F869A9C67C18

Q34997608-1A36B37A-3444-4D5F-B36A-E9A394FD8823

Q34997608-2BEE25C7-27F3-4E6C-845A-B7B344977896

Q34997608-329EE55F-FCFC-494D-A8C9-04D290EC2805

Q34997608-334CA33E-F8C3-4BE0-9036-9052F7F17671

Q34997608-3634FBF6-C62C-4CB6-958F-C517C536218E

Q34997608-40426EA5-62EB-45CA-8D03-381EECCD14EA

Q34997608-4CEDFDC5-E120-48FB-9F76-7B1518FC99E4

P304

Q34997608-5D146194-A24B-4A22-83EC-3E0F41CDC990

P31

Q34997608-4DE7CAB3-9B2F-4D37-BF51-7666A88A29F2

P356

Q34997608-562E888F-7AC2-40A3-91B3-0ABABD9E53E6

P407

Q34997608-A1A5AF47-C13B-4B83-931E-E40F81BDA8E4

P433

Q34997608-1BCEAE37-CABB-445F-AA3B-7409A14EDD2F

P478

Q34997608-58473A5F-798E-4D12-897F-F3B7C9917F4D

P50

Q34997608-25331F75-36A9-471B-9B4F-B54DDE6988C7

P577

Q34997608-A5E0F3DD-3B12-4AB5-BA27-4E033E19D629

P698

Q34997608-2037AC96-1D66-4517-98F2-C7E57DC7A35A

P932

Q34997608-7C390795-A399-4959-965C-966311F8F922

P356

J.JACI.2009.06.009

P1433

The Journal of Allergy and Clinical Immunology

P1476

Comèl-Netherton syndrome defined as primary immunodeficiency.

@en

P2093

Bernd H Belohradsky

http://www.w3.org/2001/XMLSchema#string

Dominik Hartl

http://www.w3.org/2001/XMLSchema#string

E Richard Stiehm

http://www.w3.org/2001/XMLSchema#string

Ellen D Renner

http://www.w3.org/2001/XMLSchema#string

Gary Kleiner

http://www.w3.org/2001/XMLSchema#string

Hans D Ochs

http://www.w3.org/2001/XMLSchema#string

Linda Monaco-Shawver

http://www.w3.org/2001/XMLSchema#string

M Louise Markert

http://www.w3.org/2001/XMLSchema#string

Marguerite L Young

http://www.w3.org/2001/XMLSchema#string

Melissa P Upton

http://www.w3.org/2001/XMLSchema#string

P2860

Consequences of C-terminal domains and N-terminal signal peptide deletions on LEKTI secretion, stability, and subcellular distribution

Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome

LEKTI: a multidomain serine proteinase inhibitor with pathophysiological relevance

SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases

Serine protease activity and residual LEKTI expression determine phenotype in Netherton syndrome

Chemokines--chemotactic cytokines that mediate inflammation

Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion

Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses.

P304

536-543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACI.2009.06.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19683336

http://www.w3.org/2001/XMLSchema#string

P932

3685174

http://www.w3.org/2001/XMLSchema#string